GHRH and benign prostatic hyperplasia: In vitro, GH-RH stimulated multiple pathways involved in inflammation and growth in both BPH-1 and PrEp cells, including NF-κB p65, AKT, ERK1/2, EGFR, STAT3, and increased the levels of TGF-β1 and the transactivation of the IGF receptor.